Mirasol XR Tablet 25 mg contains Mirabegron, a selective beta-3 adrenergic receptor agonist used in the management of overactive bladder (OAB). It is formulated as an extended-release (XR) tablet to provide sustained therapeutic effect throughout the day, improving bladder control while minimizing dosing frequency.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Overview

Overactive bladder is characterized by symptoms such as urinary urgency, increased urinary frequency, nocturia, and urge urinary incontinence. Mirasol XR Tablet 25 mg helps manage these symptoms by relaxing the detrusor muscle of the urinary bladder during the storage phase, thereby increasing bladder capacity and reducing involuntary contractions. Unlike antimuscarinic agents, Mirabegron works through a different mechanism and is associated with a lower risk of anticholinergic side effects.

Key Benefits

• Effective Control of Overactive Bladder Symptoms: Helps reduce urgency, frequency of urination, and episodes of urge incontinence.

• Extended-Release Formulation: Ensures steady drug release over 24 hours for consistent symptom control with once-daily dosing.

• Non-Anticholinergic Mechanism: Suitable for patients who cannot tolerate or have contraindications to antimuscarinic medications.

• Improved Quality of Life: Enhances daily comfort and confidence by improving bladder storage function.

• Well-Tolerated Profile: Generally associated with fewer side effects such as dry mouth and constipation compared to traditional therapies.

Indications

Mirasol XR Tablet 25 mg is indicated for the treatment of:

• Overactive bladder in adults

• Urinary urgency

• Increased urinary frequency

• Urge urinary incontinence

Mechanism of Action

Mirabegron selectively stimulates beta-3 adrenergic receptors in the bladder. Activation of these receptors leads to relaxation of the detrusor smooth muscle during the bladder filling phase, allowing the bladder to hold more urine without increasing pressure. This results in fewer urgent urination episodes and improved bladder control.

Dosage and Administration

The usual recommended dose is one Mirasol XR Tablet 25 mg taken orally once daily, with or without food. The tablet should be swallowed whole and should not be crushed, chewed, or broken, as this may affect the extended-release properties.

Dose adjustments may be required based on patient response, renal or hepatic function, and clinical judgment of the healthcare provider.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety Information

Mirasol XR Tablet 25 mg is generally well tolerated. Commonly reported side effects may include increased blood pressure, headache, nasopharyngitis, urinary tract infection, and mild gastrointestinal discomfort.

Caution is advised in patients with:

• Uncontrolled hypertension

• Severe renal impairment

• Severe hepatic impairment

Blood pressure should be monitored periodically during treatment, especially in patients with a history of hypertension.

Drug Interactions and Precautions

Mirabegron may interact with certain medications metabolized by specific liver enzymes. Patients should inform their healthcare provider about all current medications, including prescription drugs, over-the-counter products, and herbal supplements.

Summary

Mirasol XR Tablet 25 mg (Mirabegron) offers an effective and convenient treatment option for adults with overactive bladder. With its extended-release formulation, non-anticholinergic mechanism, and proven ability to improve bladder storage and reduce urinary symptoms, it plays a valuable role in long-term OAB management and patient quality of life.